The tumor-promoting effect of RAC1P29S was also clearly observed in BRAFV600E;Pten-hemizygous (Figures 6D–6F) and BRAFV600E;Trp53-null melanoma models (Figures 6G–6J). Here, PTEN is linked to melanoma.